Company attributes
Other attributes
Cerebral Therapeutics is a clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy. Founded 2010 in Aurora, Colorado, United States by Daniel J. Abrams, Cerebral Therapeutics is a provider of combination therapies intended to improve the lives of patients with uncontrolled neurological diseases. The company's therapies utilize reformulated off-patent drugs delivered to the ventricles of the brain in order to bypass the blood-brain barrier, enabling its clients to receive a reliable approach of treating neurological diseases for which oral infused medicines are not able to achieve adequate control.
Cerebral Therapeutics focuses on patients suffering from chronic neurological diseases, particularly those for whom oral and I.V. infused medicines are either not effective, and/or are limited by systemic medication side effects. The company’s development activities are focusing towards providing an alternative treatment to those patients who continue to have seizures despite taking conventional orally administered medications.
